The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The sphingosine kinase 1/sphingosine‐1‐phosphate pathway mediates COX‐2 induction and PGE 2 production in response to TNF‐α
Abstract
In this study we addressed the role of sphingolipid metabolism in the inflammatory response. In a L929 fibroblast model, tumor necrosis factor‐α (TNF) induced prostaglandin E 2 (PGE 2 ) production by 4 h and cyclooxygenase‐2 (COX‐2) induction as early as 2 h. This TNF‐induced PGE 2 production was inhibited by NS398, a COX‐2 selective inhibitor. GC‐MS analysis revealed that only COX‐2‐generated prostanoids were produced in response to TNF, thus providing further evidence of COX‐2 selectivity. As sphingolipids have been implicated in mediating several actions of TNF, their role in COX‐2 induction and PGE 2 production was evaluated. Sphingosine‐1‐phosphate (S1P) induced both COX‐2 and PGE 2 in a dose‐responsive manner with an apparent ED 50 of 100–300 nM. The related sphingolipid sphingosine also induced PGE 2 , though with much less efficacy. TNF induced a 3.5‐fold increase in sphingosine‐1‐phosphate levels at 10 min that rapidly returned to baseline by 40 min. Small interfering RNAs (siRNAs) directed against mouse SK1 decreased (typically by 80%) SK1 protein and inhibited TNF‐induced SK activity. Treatment of cells with RNAi to SK1 but not SK2 almost completely abolished the ability of TNF to induce COX‐2 or generate PGE 2 . By contrast, cells treated with RNAi to S1P lyase or S1P phosphatase enhanced COX‐2 induction leading to enhanced generation of PGE 2 . Treatment with SK1 RNAi also abolished the effects of exogenous sphin‐gosine and ceramide on PGE 2 , revealing that the action of sphingosine and ceramide are due to intracellular metabolism into S1P. Collectively, these results provide novel evidence that SK1 and S1P are necessary for TNF to induce COX‐2 and PGE 2 production. Based on these findings, this study indicates that SK1 and S1P could be implicated in pathological inflammatory disorders and cancer.—Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., Hannun, Y A. The sphingosine kinase 1/sphingosine‐1‐phosphate pathway mediates COX‐2 induction and PGE 2 production in response to TNF‐α, FASEB J. , 17, 1411–1421 (2003)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
CONSORT statement: extension to cluster randomised trials
Campbell, M. K., Elbourne, D. R., & Altman, D. G. (2004) · BMJ · doi:10.1136/bmj.328.7441.702 · Cited by 2,557
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Functions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,617
Self-citationSuppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
The sphingomyelin cycle and the second messenger function of ceramide.
Hannun, Y. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41834-5 · Cited by 1,235
Self-citationThe sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
KOLESNICK, R. (1994) · Cell · doi:10.1016/0092-8674(94)90147-3 · Cited by 920
Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
Olivera, A., & Spiegel, S. (1993) · Nature · doi:10.1038/365557a0 · Cited by 889
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Self-citationSphingolipid metabolism and cell growth regulation
Spiegel, S., & Merrill, A. H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.12.8903509 · Cited by 715
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Enzymes of Sphingolipid Metabolism: From Modular to Integrative Signaling
Hannun, Y. A., Luberto, C., & Argraves, K. M. (2001) · Biochemistry · doi:10.1021/bi002836k · Cited by 500
Self-citationUnraveling Function in the TNF Ligand and Receptor Families
Beutler, B., & van Huffel, C. (1994) · Science · doi:10.1126/science.8171316 · Cited by 417
An oncogenic role of sphingosine kinase
Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A. B., Wattenberg, B. W., D'Andrea, R. J., & Vadas, M. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00834-4 · Cited by 394
DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., & Bishop, P. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116998 · Cited by 373
Self-citationThe TNF-receptor-associated factor family
Wajant, H., Henkler, F., & Scheurich, P. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00160-7 · Cited by 353
Regulation of SREBP Processing and Membrane Lipid Production by Phospholipids in Drosophila
Dobrosotskaya, I. Y., Seegmiller, A. C., Brown, M. S., Goldstein, J. L., & Rawson, R. B. (2002) · Science · doi:10.1126/science.1071124 · Cited by 318
Ammit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0742fje · Cited by 313
Insights into Programmed Cell Death through Structural Biology
Fesik, S. W. (2000) · Cell · doi:10.1016/s0092-8674(00)00119-7 · Cited by 312
Mitchell, J. A., Belvisi, M. G., Akarasereenont, P., Robbins, R. A., Kwon, O. ‐., Croxtall, J. J., Barnes, P. J., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17093.x · Cited by 307
Hempel, S. L., Monick, M. M., & Hunninghake, G. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116971 · Cited by 301
Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling
Xia, P., Wang, L., Moretti, P. A. B., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R., & Vadas, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111423200 · Cited by 296
PKC-dependent Activation of Sphingosine Kinase 1 and Translocation to the Plasma Membrane
Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203033200 · Cited by 294
Self-citationExtracellular Export of Sphingosine Kinase-1 Enzyme
Ancellin, N., Colmont, C., Su, J., Li, Q., Mittereder, N., Chae, S.-S., Stefansson, S., Liau, G., & Hla, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102841200 · Cited by 280
Ballou, L. R., Chao, C. P., Holness, M. A., Barker, S. C., & Raghow, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88663-5 · Cited by 272
Xia, P., Wang, L., Gamble, J. R., & Vadas, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34499 · Cited by 270
Cuvillier, O., Rosenthal, D. S., Smulson, M. E., & Spiegel, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2910 · Cited by 255
Chen, C.-C., Sun, Y.-T., Chen, J.-J., & Chiu, K.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2719 · Cited by 197
Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E., & Baumruker, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.1 · Cited by 171
Pébay, A., Toutant, M., Prémont, J., Calvo, C., Venance, L., Cordier, J., Glowinski, J., & Tencé, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01585.x · Cited by 171
Melendez, A., Floto, R. A., Gillooly, D. J., Harnett, M. M., & Allen, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9393 · Cited by 170
Osawa, Y., Banno, Y., Nagaki, M., Brenner, D. A., Naiki, T., Nozawa, Y., Nakashima, S., & Moriwaki, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.173 · Cited by 164
Kato, M., Nishida, S., Kitasato, H., Sakata, N., & Kawai, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011778070 · Cited by 163
Phospholipase A2 Is Necessary for Tumor Necrosis Factor α-induced Ceramide Generation in L929 Cells
Jayadev, S., Hayter, H. L., Andrieu, N., Gamard, C. J., Liu, B., Balu, R., Hayakawa, M., Ito, F., & Hannun, Y. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17196 · Cited by 159
Self-citationNF-κB and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages
von Knethen, A., Callsen, D., & Brüne, B. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.2.361 · Cited by 155
Chen, C., Sun, Y.-T., Chen, J., & Chang, Y. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.493 · Cited by 132
Mifflin, R. C., Saada, J. I., Mari, J. F. D., Adegboyega, P. A., Valentich, J. D., & Powell, D. W. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00388.2001 · Cited by 125
Antiproliferative Properties of Sphingosine 1-Phosphate in Human Hepatic Myofibroblasts
Davaille, J., Gallois, C., Habib, A., Li, L., Mallat, A., Tao, J., Levade, T., & Lotersztajn, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006393200 · Cited by 118
Akarasereenont, P., Bakhle, Y. S., Thiemermann, C., & Vane, J. R. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16347.x · Cited by 87
Hayakawa, M., Jayadev, S., Tsujimoto, M., Hannun, Y. A., & Ito, F. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0464 · Cited by 87
Self-citationVann, L. R., Payne, S. G., Edsall, L. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109111200 · Cited by 76
Sphingosine 1-Phosphate Activates Nuclear Factor-κB through Edg Receptors
Siehler, S., Wang, Y., Fan, X., Windh, R. T., & Manning, D. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011072200 · Cited by 74
Statistical First Aid: Interpretation of Health Research Data.
Howel, D., Hirsch, R. P., & Riegelman, R. K. (1994) · Biometrics · doi:10.2307/2533472 · Cited by 65
Candela, M., Barker, S. C., & Ballou, L. R. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1363 · Cited by 45
Melendez, A. J., Bruetschy, L., Floto, R. A., Harnett, M. M., & Allen, J. M. (2001) · Blood · doi:10.1182/blood.v98.12.3421 · Cited by 44
Niwa, M., Kozawa, O., Matsuno, H., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00587-1 · Cited by 41
Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death
Plo, I., Ghandour, S., Feutz, A.-C., Clanet, M., Laurent, G., & Bettaïeb, A. (1999) · Neuroreport · doi:10.1097/00001756-199908020-00028 · Cited by 27
Cited by
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Self-citationSphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,051
Self-citationSphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Metadata
- Authors
- Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., & Hannun, Y. A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-08
- Volume
- 17
- Issue
- 11
- Pages
- 1411-1421
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2077827642
- Cited by
- 320
- References
- 54
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.